These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 37195698)

  • 1. Screening for 3 Genetic Conditions Is Cost-effective in Younger People.
    Harris E
    JAMA; 2023 Jun; 329(21):1818. PubMed ID: 37195698
    [No Abstract]   [Full Text] [Related]  

  • 2. msJAMA. Genomics in medicine and public health: role of cost-effectiveness analysis.
    Goldie SJ; Levin AR
    JAMA; 2001 Oct; 286(13):1637-8. PubMed ID: 11585493
    [No Abstract]   [Full Text] [Related]  

  • 3. Cost-effectiveness of preimplantation genetic testing for aneuploidies.
    Somigliana E; Busnelli A; Paffoni A; Vigano P; Riccaboni A; Rubio C; Capalbo A
    Fertil Steril; 2019 Jun; 111(6):1169-1176. PubMed ID: 30777289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Probabilistic cost-effectiveness analysis of cascade screening for familial hypercholesterolaemia using alternative diagnostic and identification strategies.
    Nherera L; Marks D; Minhas R; Thorogood M; Humphries SE
    Heart; 2011 Jul; 97(14):1175-81. PubMed ID: 21685482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Economic evidence on identifying clinically actionable findings with whole-genome sequencing: a scoping review.
    Douglas MP; Ladabaum U; Pletcher MJ; Marshall DA; Phillips KA
    Genet Med; 2016 Feb; 18(2):111-6. PubMed ID: 25996638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic tests for many rare diseases headed for orphan status.
    Kuska B
    J Natl Cancer Inst; 1997 Dec; 89(23):1748-9. PubMed ID: 9392610
    [No Abstract]   [Full Text] [Related]  

  • 7. The Impact of Biomarker Screening and Cascade Genetic Testing on the Cost-Effectiveness of MODY Genetic Testing.
    GoodSmith MS; Skandari MR; Huang ES; Naylor RN
    Diabetes Care; 2019 Dec; 42(12):2247-2255. PubMed ID: 31558549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic testing and economic evaluations: a systematic review of the literature.
    D'Andrea E; Marzuillo C; Pelone F; De Vito C; Villari P
    Epidemiol Prev; 2015; 39(4 Suppl 1):45-50. PubMed ID: 26499415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A cost-effectiveness model of genetic testing and periodical clinical screening for the evaluation of families with dilated cardiomyopathy.
    Catchpool M; Ramchand J; Martyn M; Hare DL; James PA; Trainer AH; Knight J; Goranitis I
    Genet Med; 2019 Dec; 21(12):2815-2822. PubMed ID: 31222143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequencing projects will screen 200,000 newborns for disease.
    Kaiser J
    Science; 2022 Dec; 378(6625):1159. PubMed ID: 36520905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flunk the gene test and lose your insurance.
    Cowley G
    Newsweek; 1996 Dec; 128(26):48-50. PubMed ID: 10163863
    [No Abstract]   [Full Text] [Related]  

  • 12. Cost-Effectiveness of Personalized Screening for Colorectal Cancer Based on Polygenic Risk and Family History.
    Cenin DR; Naber SK; de Weerdt AC; Jenkins MA; Preen DB; Ee HC; O'Leary PC; Lansdorp-Vogelaar I
    Cancer Epidemiol Biomarkers Prev; 2020 Jan; 29(1):10-21. PubMed ID: 31748260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Economics of genetics from a health commissioning point of view.
    Turner RD
    Dis Markers; 1999 Oct; 15(1-3):175-6. PubMed ID: 10595274
    [No Abstract]   [Full Text] [Related]  

  • 14. Cost-effectiveness analysis of prenatal diagnosis: methodological issues and concerns.
    Caughey AB
    Gynecol Obstet Invest; 2005; 60(1):11-8. PubMed ID: 15692215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proband-only medical exome sequencing as a cost-effective first-tier genetic diagnostic test for patients without prior molecular tests and clinical diagnosis in a developing country: the China experience.
    Hu X; Li N; Xu Y; Li G; Yu T; Yao RE; Fu L; Wang J; Yin L; Yin Y; Wang Y; Jin X; Wang X; Wang J; Shen Y
    Genet Med; 2018 Sep; 20(9):1045-1053. PubMed ID: 29095814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Significance of an adequate design in genetic diagnosis protocols].
    Perez-Soriano C; Adam V; Martinez-Costa C; Garcia-Garcia AB
    Med Clin (Barc); 2014 Apr; 142(8):375-6. PubMed ID: 24012447
    [No Abstract]   [Full Text] [Related]  

  • 17. Genetics and managed care: Policy statement of the American College of Medical Genetics.
    Williams MS
    Genet Med; 2001; 3(6):430-5. PubMed ID: 11715009
    [No Abstract]   [Full Text] [Related]  

  • 18. Screening for Lynch syndrome: it is time to shift the focus.
    Kidambi TD; Terdiman JP
    Dig Dis Sci; 2015 Feb; 60(2):586-7. PubMed ID: 25563721
    [No Abstract]   [Full Text] [Related]  

  • 19. Variables that underlie cost efficacy of prenatal screening.
    Kinzler WL; Morrell K; Vintzileos AM
    Obstet Gynecol Clin North Am; 2002 Jun; 29(2):277-86, v-vi. PubMed ID: 12108828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reply: To PMID 24957400.
    Gould-Suarez M; El-Serag HB; Musher B; Franco LM; Chen GJ
    Dig Dis Sci; 2015 Feb; 60(2):587. PubMed ID: 25756151
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.